![]() Impel Pharmaceuticals Impel Pharmaceuticals (formerly known as Impel NeuroPharma) is a pharmaceutical company that develops and commercializes therapies for patients suffering from central nervous system diseases. | Hovione Farmaciencia Hovione Farmaciência is a company that develops and manufactures pharmaceutical products. | ||
Founding Date | Founding Date 1998 | Founding Date 2008 | Founding Date 1959 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Beckley, GB HQ | Locations Seattle, US HQ | |
Employees | Employees N/A | Employees 6710% increase | Employees 2,4393% increase |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $12.7m (FY, 2022) | Revenue (est.) $504m (FY, 2024) |
Funding | |||
Total funding raised | Total funding raised $ 22.6m | Total funding raised $ 108.1m | Total funding raised N/A |

Impel Pharmaceuticals (formerly known as Impel NeuroPharma) is a pharmaceutical company that develops and commercializes therapies for patients suffering from central nervous system diseases.
View companyHovione Farmaciência is a company that develops and manufactures pharmaceutical products.
View company